脳のマイクロエンボリズムは,選択的な非ペプチド性血小板グリコプロテインIIb/IIIa受容体アンタゴニストであるチロフィバンによって阻害されます
Ulrich Junghans1, Mario Siebler
1Department of Neurology, Heinrich-Heine University, Moorenstrasse 5, D-40225 Düsseldorf, Germany.
Circulation
|May 14, 2003
まとめ
糖タンパク質IIb/IIIaの抗体であるチロフィバンは,大動脈疾患の患者でマイクロエンボリックシグナル (MES) を効果的に除去しました. これは,血小板-線維原素単位が脳微血栓形成の鍵であり,GPIIb/IIIa抗体が脳卒中リスクを減らす可能性があることを示唆しています.
科学分野:
- 神経科学は神経科学である.
- 心血管医学 心血管医学
- 薬理学 薬理学とは
背景:
- トランスクラニアルドップラー超音波で検出されたマイクロエンボリック信号 (MES) は,頸動脈疾患における脳卒中リスクを示している.
- MESの組成を理解することは,脳卒中予防戦略にとって極めて重要です.
研究 の 目的:
- マイクロエボリックシグナル (MES) のインビボ組成を調査する.
- グリコプロテインIIb/IIIa受容体アンタゴニストであるチロフィバンのMESを抑制する効果を評価する.
主な方法:
- 最近の動脈栓塞と高いMES率を有する24人の患者がチロフィバンを受けた.
- MESの割合は,チロフィバンの輸注前,その間,およびその後にモニタリングされました.
- 口服抗血小板剤の重複効果も評価された.
主要な成果:
- ティロフィバンは,すべての患者でMES率を平均38からゼロに低下させた.
- 抑制効果は,チロフィバンの輸注を中止すると逆戻りした.
- オーラル抗血小板剤を併用した6人の患者はMES陰性でした.
結論:
- 脳のマイクロエンボリズムは,主に血小板-線維原素単位で構成される固体エンボリーであるようです.
- グリコプロテインIIb/IIIaアンタゴニストは,不安定な頸動脈疾患における缺血リスクの橋渡しとなる可能性を示しています.
関連する概念動画
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...